These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8435825)

  • 1. Pharmacologic therapy in patients with ventricular tachyarrhythmias.
    Wyse DG
    Cardiol Clin; 1993 Feb; 11(1):65-83. PubMed ID: 8435825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists in treatment of ventricular tachycardia].
    Melichercik J; Schöls W; Beyer T; Schweizer M; Brachmann J; Kübler W
    Z Kardiol; 1996 May; 85(5):319-25. PubMed ID: 8711944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?].
    Steinbeck G
    Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventricular tachyarrhythmias in patients without structural heart disease. Clinical and electrophysiologic characteristics of the tachyarrhythmias and long-term results of catheter ablation].
    Fiala M; Heinc P; Bulava A; Lukl J
    Vnitr Lek; 2001 Dec; 47(12):817-28. PubMed ID: 11826544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study].
    Brandão L; Carpinteiro L; Sousa J; Vagueiro MC
    Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome.
    Furushima H; Chinushi M; Sugiura H; Komura S; Tanabe Y; Watanabe H; Washizuka T; Aizawa Y
    J Electrocardiol; 2006 Apr; 39(2):219-24. PubMed ID: 16580423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent therapeutic strategy for sustained ventricular tachycardia in Japan.
    Ogura H; Katoh T; Kasanuki H; Iinuma H; Ozawa Y; Majima S; Hayakawa H
    Heart Vessels; 1997; Suppl 12():162-4. PubMed ID: 9476570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic treatment for ventricular arrhythmias].
    Halawa B
    Pol Merkur Lekarski; 1997 Aug; 3(14):45-9. PubMed ID: 9480172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of chronic ventricular arrhythmia].
    Motté G; Slama M; Dinanian S; Sebag C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():85-9. PubMed ID: 1284883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained monomorphic ventricular tachycardia in patients with structural heart disease. Different arrhythmogenic substrates, different options of palliative and curative treatment in the era of three-dimensional mapping].
    Fiala M; Chovanzík J; Neuwirth R; Nykl I; Szymeczek H; Nevralová R; Jiravský O; Branny M
    Vnitr Lek; 2006 Jun; 52(6):577-89. PubMed ID: 16871761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.